A crystal structure of the complex between human complement receptor 2 and its ligand C3d

Science

Volumn 332, Issue 6029, 2011, Pages 608-611

  Van Den Elsen, Jean M H ^a   Isenman, David E ^b  

^a University of Bath   (United Kingdom)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3D; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR 2; LIGAND; UNCLASSIFIED DRUG;

ADAPTATION; ANTIBODY; BIOCHEMISTRY; BRAIN; CRYSTAL STRUCTURE; CRYSTALLIZATION; DISEASE TREATMENT; IMMUNE SYSTEM; LIGAND; PUBLIC HEALTH; VACCINE; ZINC;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; BIOSENSOR; COMPLEMENT SYSTEM; COMPLEX FORMATION; CRYSTAL STRUCTURE; DENDRITIC CELL; HUMAN; INNATE IMMUNITY; MUTAGENESIS; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE;

BINDING SITES; COMPLEMENT C3D; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; HUMANS; HYDROGEN BONDING; LIGANDS; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, COMPLEMENT 3D; ZINC ACETATE;

EID: 79955533554     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1201954     Document Type: Article

References (29)

1. R. Roozendaal, M. C. Carroll, Immunol. Rev. 219, 157 (2007).
2. P. W. Dempsey, M. E. D. Allison, S. Akkaraju, C. C. Goodnow, D. T. Fearon, Science 271, 348 (1996).
3. Y. Fang, C. Xu, Y. X. Fu, V. M. Holers, H. Molina, J. Immunol. 160, 5273 (1998).
4. C. J. Del Nagro, R. V. Kolla, R. C. Rickert, J. Immunol. 175, 5379 (2005).
5. K. A. Kuhn, C. L. Cozine, B. Tomooka, W. H. Robinson, V. M. Holers, Mol. Immunol. 45, 2808 (2008).
6. K. R. Kalli, J. M. Ahearn, D. T. Fearon, J. Immunol. 147, 590 (1991).
7. G. Szakonyi et al., Science 292, 1725 (2001).
8. J. M. Guthridge et al., Biochemistry 40, 5931 (2001).
9. C. A. Lowell et al., J. Exp. Med. 170, 1931 (1989).
10. J. C. Carel, B. L. Myones, B. Frazier, V. M. Holers, J. Biol. Chem. 265, 12293 (1990).
11. L. Clemenza, D. E. Isenman, J. Immunol. 165, 3839 (2000).
12. B. Nagar, R. G. Jones, R. J. Diefenbach, D. E. Isenman, J. M. Rini, Science 280, 1277 (1998).
13. M. D. Moore, R. G. DiScipio, N. R. Cooper, G. R. Nemerow, J. Biol. Chem. 264, 20576 (1989).
14. R. J. Diefenbach, D. E. Isenman, J. Immunol. 154, 2303 (1995).
15. Single-letter abbreviations for the amino acid residues are as follows: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; and Y, Tyr.
16. D. E. Isenman, E. Leung, J. D. Mackay, S. Bagby, J. M. van den Elsen, J. Immunol. 184, 1946 (2010).
17. For data-collection statistics, see table S1 in the supporting material on Science Online. For protein expression, characterization, and crystallization conditions, see the supporting materials and methods text, as well as figs. S1 and S2.
18. A. E. Prota, D. R. Sage, T. Stehle, J. D. Fingeroth, Proc. Natl. Acad. Sci. U.S.A. 99, 10641 (2002).
19. J. P. Hannan et al., J. Mol. Biol. 346, 845 (2005).
20. J. M. Kovacs, J. P. Hannan, E. Z. Eisenmesser, V. M. Holers, J. Biol. Chem. 284, 9513 (2009).
21. J. D. Burman et al., J. Biol. Chem. 283, 17579 (2008).
22. D. Ricklin, S. K. Ricklin-Lichtsteiner, M. M. Markiewski, B. V. Geisbrecht, J. D. Lambris, J. Immunol. 181, 7463 (2008).
23. E. A. Clark et al., Mol. Immunol. 48, 452 (2011).
24. M. Hammel et al., Nat. Immunol. 8, 430 (2007).
25. B. J. Janssen, A. Christodoulidou, A. McCarthy, J. D. Lambris, P. Gros, Nature 444, 213 (2006).
26. N. Nishida, T. Walz, T. A. Springer, Proc. Natl. Acad. Sci. U.S.A. 103, 19737 (2006).
27. J. D. Lambris, V. S. Ganu, S. Hirani, H. J. Müller-Eberhard, Proc. Natl. Acad. Sci. U.S.A. 82, 4235 (1985).
28. M. R. Sarrias et al., J. Immunol. 167, 1490 (2001).
29. C. D. Shaw et al., J. Mol. Biol. 404, 697 (2010).